arrow
F

Francisco Pérez-Miralles

La Fe University and Polytechnic Hospital
H指数:25
被引数:1,910

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Safety, Effectiveness and Discontinuation of Rituximab in CNS Demyelinating Disorders: A 6-Year Real-World Cohort Study

利妥昔单抗在中枢神经系统脱髓鞘疾病中的长期安全性、有效性与停药情况:一项为期6年的真实世界队列研究

2026-11-120
PRE
Tear CHI3L1 in multiple sclerosis: a non-invasive biomarker linked to disease progression

多发性硬化中的Tear CHI3L1:一种与疾病进展相关的非侵入性生物标志物

2026-06-100
PRE
Relapse-Associated versus Relapse-Independent Progression Determines Disability Trajectories in Multiple Sclerosis Beyond EDSS 3.0

复发相关与复发独立进展决定EDSS 3.0以上多发性硬化的残疾轨迹

2026-05-300
PRE
An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing

预测多发性硬化患者鞘内IgM合成的算法:优化寡克隆带检测的使用

2025-12-010
OAAI
Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays

多平台分析评估血清GFAP在多发性硬化中的定量:SIMOA与两种自动化免疫检测方法的比较

2025-10-200
OAAI
Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study (Dec, 10.1007/s10072-024-07921-x, 2024)

动态18 F-FDG PET检测进行性和复发型多发性硬化症患者差异:一项初步研究(2024年12月,10.1007/s10072-024-07921-x)

2024-12-300
PRE
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis
BRAIN
IF11.7
2024-08-052
PRE
Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis
2024-07-011
OAAI
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis

血清生物标志物水平预测原发性进行性多发性硬化患者的残疾进展

2023-11-086
PRE
Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional Study
2022-05-0610
OAAI
Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder
2022-05-027
OAAI
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
2022-03-0712
OAAI
SARS-CoV-2 Infection in Multiple Sclerosis Results of the Spanish Neurology Society Registry
2021-09-0128
OAAI
Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study)

一组原发性进行性多发性硬化症患者的疾病活动,认知,情绪,污名和就业结果的短期数据 (UPPMS研究)

2021-05-019
PREAI